Detailed Insight into Debt and Fixed Income

Seeking Sustained Growth in Enterprise Value

We continually strive to be a reliable and valued partner in the financial markets. Debt capital investors are key to our financing strategy and success. For your convenience, we’ve provided below a variety of resources including our debt investor presentation as a summary overview, our key ratings and current bonds outstanding.

 

Our Debt Investor presentation streamlines our key credit-related data into one accessible document.

 

 

If you have any further questions related to debt capital, please do not hesitate to contact us.

 

Bonds Outstanding

Bayer refinances the business mainly through U.S. Dollar and Euro debt capital markets. Below you find a list of all currently outstanding bonds issued by Bayer Group entities. Please note that we cannot provide prospectuses for any of these securities for legal reasons.

 

Rating

Ratings from internationally recognized agencies allow lenders to assess the risk inherent in financial instruments as companies seek to raise funds in the capital markets by issuing bonds, commercial paper, or other debt instruments. These agencies have confirmed the following ratings, which allow us to access capital markets to issue bonds. With a proven track record of disciplined deleveraging, Bayer remains committed to meeting the “A” target category rating through the long-term.

Rating agency

Long-term rating

Short-term rating

Outlook

S&P Global Ratings

BBB

A2

stable

Moody's

Baa1

P2

Negative

Fitch Ratings

BBB+

F2

stable

 

The analysts responsible for Bayer’s credit rating are:

S&P Global Ratings

Nicolas Baudouin

Tel +33-1442-06672

E-Mail: nicolas.baudouin@spglobal.com

Moody's

Moritz Melsbach

Tel +49-69-70730-784

E-Mail: moritz.melsbach@moodys.com

Fitch Ratings

Xavier Taulé Flores

Tel +34-93492-9513

E-Mail: xavier.tauleflores@fitchratings.com

 

Debt Investor News

Below you will find all bond-related investor news.

 

Investor News July 01, 2020

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer issues new senior bonds with a volume of 6 billion euros

Issuance of four tranches with maturities between 4 and 12 years was substantially oversubscribed MORE


Investor News November 07, 2019

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer refinances 1.75 billion euro hybrid bond

New issue of two tranches with a non-call period of 5.5 and 8 years combined with a tender offer for Bayer's existing hybrid bond MORE


Investor News December 18, 2018

Bayer extends credit line and increases volume to 4.5 billion euros

MORE


Investor News June 07, 2017

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN

Bayer places 8.5 percent of Covestro's shares and EUR 1 billion bonds exchangeable into Covestro shares

Issue of four tranches with maturities of 4 to 11½ years was more than four times oversubscribed MORE


Investor News November 16, 2016

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA

Bayer successfully places EUR 4 billion of mandatory convertible notes

 


Investor News November 15, 2016

NOT FOR DISTRIBUTION IN THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA

Bayer to issue mandatory convertible notes

 


Investor News April 15, 2015

Bayer to early redeem EUR 1.3 billion bond issued in 2005

 


Investor News March 30, 2015

Bayer issues EUR 1.3 billion in hybrid capital

 


Investor News October 02, 2014

Bayer launches jumbo bond issuance with a volume of USD 7 billion

Successful placement as part of the financing of the acquisition of the OTC business of Merck & Co., Inc., United States / Six tranches with maturities of two to ten years 


Investor News June 25, 2014

Not intended for U.S. Media - To finance the acquisition of the consumer care business of Merck & Co., Inc.

Bayer issues hybrid capital of EUR 3.25 billion

Largest corporate euro hybrid bond transaction worldwide 


Investor News January 21, 2014

Bayer issues EUR 2 billion of bonds

Transaction comprises two-year floating-rate tranche and two EUR 750 million fixed-rate bonds with maturities of four and seven years